Loading Nifty 50, Nifty Bank, and Sensex…
Sai Life Sciences Limited
SAILIFE · Corporate filings
NSE
Sai Life Sciences Limited
SAILIFE · NSE · Healthcare
₹1,905.20
-0.7%
As of 12 Nov 2026
Sai Life Sciences Limited (SAILIFE) is listed on NSE in the Healthcare sector. It last traded at ₹1,905.20, down 0.7% on the session. Its 52-week range is ₹783.85 to ₹1,941.80.
Research output is rule-based and informational only. It is not investment advice.
Analytics for SAILIFE are not available yet. Technicals, fundamentals, peer ranking
and risk notes appear here once this listing's daily history and annual filings are synced.
Financial Charts & Report
Stock market charts for Sai Life Sciences Limited quarterly results: revenue, profit, margins, growth, and filing-derived operating metrics.
Loading financial charts...
Results Change Summary quarter-on-quarter and year-on-year filing evidence
Generate an evidence-linked summary of revenue, margin, profit, debt, cash and operating cash flow changes.
Financial Results figures in ₹ crore, except EPS/%
Loading…
Relative Returns stock, sector, and exchange benchmarks
Loading…
CAN SLIM William O'Neil's growth-stock criteria
Loading…
Latest Shareholding Pattern promoter, FII, DII, public and institution trend
Corporate Governance SEBI integrated governance filing
Loading governance disclosure...
Announcements
Announcement
Market activity
Short selling - 516 shares
Announcement
Announcement
Announcement
Announcement
Announcement
Announcement
Market activity
Short selling - 10 shares
Market activity
Short selling - 20 shares
Announcement
News
Loading…
Corporate Actions dividends, bonuses, splits, buybacks, rights
Full history
No corporate actions available right now.
Board Meetings
05 Nov 2026
Sai Life Sciences Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.
06 Aug 2026
Sai Life Sciences Limited has submitted to the Exchange, the unaudited financial results (Standalone and Consolidated) for the period ended Jun 30, 2026.
14 May 2026
Sai Life Sciences Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.